TC
FCSC

TFS Capital’s Fibrocell Science Inc. FCSC Stock Holding History

TFS Capital’s Portfolio FCSC Stock Details FCSC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-1,387
Closed -$52K – 1287
2016
Q1 		$52K Buy
+1,387
New +$55.4K 0.01% 947
2014
Q3 		– Sell
-1,248
Closed -$75K – 1303
2014
Q2 		$75K Buy
+1,248
New +$69.6K 0.01% 1069

Other funds holding FCSC

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

TFS Capital's FCSC Position: Q2 2016 in Review

TFS Capital sold out of Fibrocell Science Inc. (FCSC) in Q2 2016, closing a stake of 1,387 shares — an estimated $52K sold.

TFS Capital first reported a position in FCSC in Q2 2014 and held it in 2 quarters. The position peaked at $75K in Q2 2014. 44 funds tracked by Wall St. Rank hold FCSC as of Q2 2016.

  • TFS Capital reported no remaining Fibrocell Science Inc. position as of Q2 2016 after selling out during the quarter.
  • TFS Capital sold 1,387 Fibrocell Science Inc. shares in Q2 2016, an estimated $52K.
  • TFS Capital first reported a position in Fibrocell Science Inc. in Q2 2014 and held it in 2 quarters.
  • TFS Capital's Fibrocell Science Inc. position peaked at $75K in Q2 2014.
  • 44 funds tracked by Wall St. Rank held Fibrocell Science Inc. as of Q2 2016.

Based on TFS Capital's 13F filing for Q2 2016, filed 11 Aug 2016.